VIPoma surgery: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 9: | Line 9: | ||
*If the tumor cannot be removed completely, surgical debulking may have palliative effect for control of hormonal symptoms.<ref name="sp">Vinik A. Vasoactive Intestinal Peptide Tumor (VIPoma) [Updated 2013 Nov 28]. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK278960/</ref> | *If the tumor cannot be removed completely, surgical debulking may have palliative effect for control of hormonal symptoms.<ref name="sp">Vinik A. Vasoactive Intestinal Peptide Tumor (VIPoma) [Updated 2013 Nov 28]. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK278960/</ref> | ||
*In nonresectable liver metastases, Hepatic [[Transcatheter arterial chemoembolization|TACE]] (transarterial chemoembolization) is emerging as a new non-emergency therapeutic modality highly successful for control of VIP-related symptoms.<ref name="pmid4981295">{{cite journal| author=Blaise A, Girardet JL| title=[Study of the magnetic properties of siderophilin]. | journal=C R Acad Sci Hebd Seances Acad Sci D | year= 1969 | volume= 269 | issue= 10 | pages= 966-8 | pmid=4981295 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4981295 }}</ref> | *In nonresectable liver metastases, Hepatic [[Transcatheter arterial chemoembolization|TACE]] (transarterial chemoembolization) is emerging as a new non-emergency therapeutic modality highly successful for control of VIP-related symptoms.<ref name="pmid4981295">{{cite journal| author=Blaise A, Girardet JL| title=[Study of the magnetic properties of siderophilin]. | journal=C R Acad Sci Hebd Seances Acad Sci D | year= 1969 | volume= 269 | issue= 10 | pages= 966-8 | pmid=4981295 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4981295 }}</ref> | ||
[[Image:Intra_operative.jpg|center|400px|thumb|Intraoperative aspect of liver lesions (arrows).]] | |||
==References== | ==References== | ||
Revision as of 20:25, 19 January 2018
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma surgery On the Web |
|
American Roentgen Ray Society Images of VIPoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]Parminder Dhingra, M.D. [3]
Overview
Surgery is the mainstay of treatment for VIPoma.
Surgery
- Surgery should be considered after initial symptomatic management of VIPoma in operable cases.
- Complete surgical resection of tumor is the only curative treatment for VIPoma. The feasibility of surgery depends on the stage of VIPoma at diagnosis.[1]
- If the tumor cannot be removed completely, surgical debulking may have palliative effect for control of hormonal symptoms.[2]
- In nonresectable liver metastases, Hepatic TACE (transarterial chemoembolization) is emerging as a new non-emergency therapeutic modality highly successful for control of VIP-related symptoms.[3]
References
- ↑ Pancreatic Neuroendocrine Tumors (Islet Cell Tumors). National Cancer Institute. http://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq#section/_78. Accessed on October 21, 2015.
- ↑ Vinik A. Vasoactive Intestinal Peptide Tumor (VIPoma) [Updated 2013 Nov 28]. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK278960/
- ↑ Blaise A, Girardet JL (1969). "[Study of the magnetic properties of siderophilin]". C R Acad Sci Hebd Seances Acad Sci D. 269 (10): 966–8. PMID 4981295.